With a median follow-up of @ months ( IQR @-@ ) , disease-free survival at @ years was @ % ( @ % CI @-@ ) in the investigational group and @ % ( @ % CI @-@ ) in the control group ( hazard ratio -LSB- HR -RSB- @ , @ % CI @-@ ; p = @ ) .